(Q38801673)

6 September 2017

0 references

1 reference

title

Interventions for idiopathic steroid-resistant nephrotic syndrome in children (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457874&resulttype=core&format=json

13 May 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457874&resulttype=core&format=json

13 May 2020

author name string

Elisabeth M Hodson

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457874&resulttype=core&format=json

13 May 2020

Sophia C Wong

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457874&resulttype=core&format=json

13 May 2020

Narelle S Willis

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457874&resulttype=core&format=json

13 May 2020

publication date

11 October 2016

1 reference

Cochrane Database of Systematic Reviews

6 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457874&resulttype=core&format=json

13 May 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457874&resulttype=core&format=json

13 May 2020

page(s)

CD003594

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457874&resulttype=core&format=json

Cyclosporin A is superior to cyclophosphamide in children with steroid-resistant nephrotic syndrome-a randomized controlled multicentre trial by the Arbeitsgemeinschaft für Pädiatrische Nephrologie

13 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Enalapril dosage in steroid-resistant nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Intravenous pulse cyclophosphamide--a new regime for steroid-resistant minimal change nephrotic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Association of histologic variants in FSGS clinical trial with presenting features and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Patient recruitment into a multicenter randomized clinical trial for kidney disease: report of the focal segmental glomerulosclerosis clinical trial (FSGS CT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Clinical trial of focal segmental glomerulosclerosis in children and young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Renal function and proteinuria after successful immunosuppressive therapies in patients with FSGS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Cyclosporine therapy for steroid-resistant nephrotic syndrome. A controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Rituximab in children with resistant idiopathic nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Efficacy of intravenous pulse cyclophosphamide treatment versus combination of intravenous dexamethasone and oral cyclophosphamide treatment in steroid-resistant nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

A controlled trial of cyclophosphamide and azathioprine in Nigerian children with the nephrotic syndrome and poorly selective proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Tacrolimus versus cyclophosphamide in steroid-dependent or steroid-resistant focal segmental glomerulosclerosis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Significance of combined cyclosporine-prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

A randomized open-label comparative study of conventional therapy versus mizoribine onlay therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

The effect of treatment of corticosteroid-resistant idiopathic (primary) focal and segmental hyalinosis and sclerosis (focal glomerulosclerosis) with ciclosporin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Initial steroid sensitivity in children with steroid-resistant nephrotic syndrome predicts post-transplant recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Nephrotic syndrome in The Netherlands: a population-based cohort study and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Differential risk of remission and ESRD in childhood FSGS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

What is meant by intention to treat analysis? Survey of published randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Long-term outcome of primary nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Steroid-resistant nephrotic focal segmental glomerulosclerosis: a treatable disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Interventions for steroid-resistant nephrotic syndrome: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Interventions for idiopathic steroid-resistant nephrotic syndrome in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Interventions for idiopathic steroid-resistant nephrotic syndrome in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Interventions for idiopathic steroid-resistant nephrotic syndrome in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Predictors of remission and relapse in idiopathic nephrotic syndrome: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003594.PUB5

Effects of tuna fish oil on hyperlipidemia and proteinuria in childhood nephrotic syndrome

21 January 2018

1 reference

12 December 2020

Older boys benefit from higher initial prednisolone therapy for nephrotic syndrome. The West Japan Cooperative Study of Kidney Disease in Children

1 reference

12 December 2020

The effects of gemfibrozil on hyperlipidemia in children with persistent nephrotic syndrome

1 reference

12 December 2020

Effect of fluvastatin and dipyridamole on proteinuria and renal function in childhood IgA nephropathy with mild histological findings and moderate proteinuria.

1 reference

12 December 2020

Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. The French Society of Paediatric Nephrology

1 reference

12 December 2020

Comparative study of angiotensin converting enzyme inhibitor and calcium channel blocker in the treatment of steroid-resistant idiopathic nephrotic syndrome.

1 reference

12 December 2020

No effect of fluvastatin on the bone mineral density of children with minimal change glomerulonephritis and some focal mesangial cell proliferation, other than an ameliorating effect on their proteinuria

1 reference

12 December 2020

Effect of fosinopril in children with steroid-resistant idiopathic nephrotic syndrome

1 reference

12 December 2020

Steroid sparing effect of a herbal preparation in steroid-dependent nephrotic syndrome

1 reference

12 December 2020

Idiopathic nephrotic syndrome in New Zealand children, demographic, clinical features, initial management and outcome after twelve-month follow-up: results of a three-year national surveillance study

1 reference

12 December 2020

Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated

1 reference

12 December 2020

The clinical effectiveness and cost-effectiveness of treatments for children with idiopathic steroid-resistant nephrotic syndrome: a systematic review.

1 reference

12 December 2020

Immunosuppressive treatment of focal segmental glomerulosclerosis: lessons from a randomized controlled trial

1 reference

12 December 2020

Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical Trial

1 reference

12 December 2020

Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Report of the International study of Kidney Disease in Children

1 reference

12 December 2020

Controlled trial of azathioprine in children with nephrotic syndrome. A report for the international study of kidney disease in children

1 reference

12 December 2020

Irreversible renal failure after indomethacin in steroid-resistant nephrosis.

1 reference

12 December 2020

The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children

1 reference

12 December 2020

Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up

1 reference

12 December 2020

Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisone. French Society of Pediatric Nephrology

1 reference

12 December 2020

Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.

1 reference

12 December 2020

A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children

1 reference

12 December 2020

10.1002/14651858.CD003594.PUB5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457874&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457874&resulttype=core&format=json

13 May 2020

1 reference